Japan's Fujitsu to Sell Controlling Stake in Chip-Packaging Unit
By Ronnie Harui
Fujitsu has agreed to sell a controlling stake in its semiconductor-packaging unit to a consortium of investors who plan to take the business private in a roughly $4.7 billion deal.
Under the agreement, the Japanese electronics company will sell Shinko Electric Industries to a special-purpose company owned by a consortium led by JIC Capital, a wholly-owned subsidiary of government-backed Japan Investment Corp.
Fujitsu plans to transfer its 50.03% stake in Shinko Electric to JICC-04, a special-purpose vehicle owned by the consortium, for 285.1 billion yen ($1.96 billion), it said late Tuesday.
The move is aimed at speeding up Fujitsu's efforts to transform its portfolio, the company said, adding that it would use the cash from the deal to invest in areas of growth.
The consortium, which also comprises Dai Nippon Printing and Mitsui Chemicals, ultimately aims to take Shinko Electric private, JIC and JIC Capital said in a joint statement. It intends to launch a tender offer for the Shinko shares not held by Fujitsu, offering Y5,920 for each--a 13% premium to Tuesday's closing price--amounting to Y399.8 billion.
Shinko shares were last flat at Y5,527, while Fujitsu shares were 2.9% lower at Y21,605.
Write to Ronnie Harui at ronnie.harui@wsj.com
(END) Dow Jones Newswires
December 12, 2023 22:58 ET (03:58 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
What’s the Difference Between the CPI and PCE Indexes?
-
Micron Earnings: Great Guidance but Stock Now Looks Fairly Valued
-
August PCE Report Forecasts Show More Good News on Inflation
-
AI Stocks May Be Down, but Don’t Count Them Out
-
4 Stocks to Buy as the Fed Cuts Interest Rates
-
Markets Brief: The Uncertain Path to Neutral Interest Rates
-
What’s Happening in the Markets This Week
-
Where Top Stock Fund Managers Are Looking Next After the Fed Rate Cut
-
Our Top Pick for Investing in US Renewable Energy
-
How to Measure a Stock’s Uncertainty
-
How to Determine Whether a Stock Is Cheap, Expensive, or Fairly Valued
-
Why a Company’s Management and Capital Allocation Matter
-
How to Determine What a Stock Is Worth
-
How to Measure a Company’s Competitive Advantage
-
How to Think Like a Stock Analyst
-
How GLP-1 Drugs Like Ozempic Are Boosting Biopharma Stocks